APA citiranje

Chen, D., Chu, T., Chang, Q., Zhang, Y., Xiong, L., Qiao, R., . . . Zhong, R. (2019). The relationship between preliminary efficacy and prognosis after first-line EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment of advanced non-small cell lung cancer. Ann Transl Med.

Citação norma Chicago

Chen, Dongfang, Tianqing Chu, Qing Chang, Yanwei Zhang, Liwen Xiong, Rong Qiao, Jiajun Teng, Baohui Han, and Runbo Zhong. "The Relationship between Preliminary Efficacy and Prognosis After First-line EGFR Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment of Advanced Non-small Cell Lung Cancer." Ann Transl Med 2019.

MLA citiranje

Chen, Dongfang, et al. "The Relationship between Preliminary Efficacy and Prognosis After First-line EGFR Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment of Advanced Non-small Cell Lung Cancer." Ann Transl Med 2019.

Opozorilo: Ti citati niso vedno 100% točni.